Kymera Therapeutics, Inc. Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

KYMR

Pozycja w akcjach #2280
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Cena akcji
$107.81
Kapitalizacja rynkowa
$8.87B
Zmiana (1 dzień)
2.89%
Zmiana (1 rok)
80.19%
Kraj
US
Handel Kymera Therapeutics, Inc. (KYMR)

Kategoria

Healthcare
EPS dla Kymera Therapeutics, Inc. (KYMR)
EPS na dzień June 2026 TTM: $-3.25
Według najnowszych raportów finansowych i ceny akcji firmy Kymera Therapeutics, Inc., obecny EPS (TTM) wynosi $-3.25. Na koniec roku 2023 firma miała EPS w wysokości $-2.52, spadek w porównaniu do do EPS z roku 2022, który wynosił $-2.87.
Historia EPS dla Kymera Therapeutics, Inc. od 2018 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-3.25 9.06%
2024 $-2.98 18.25%
2023 $-2.52 -12.20%
2022 $-2.87 37.32%
2021 $-2.09 111.11%
2020 $-0.99 6.45%
2019 $-0.93 93.75%
2018 $-0.48 0.00%
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$17.32 -632.92%
US
$-7.98 145.54%
US
$-5.29 62.77%
AU
- -
CH
$27.74 -953.54%
NL